China’s Declining Demand Impacts Oil Prices
Oil prices eased on Monday, with global benchmark Brent crude slipping below the $80 mark, as concerns over China’s weakening demand, the world’s largest oil
Home
Page 224
China’s EV Incentives Drive NIO, XPeng, and Li Auto Stocks Higher
Chinese electric vehicle (EV) stocks are rallying as NIO Inc. (NYSE: NIO), XPeng Inc. (NYSE: XPEV), and Li Auto Inc. (NASDAQ: LI) all surged in
Lumen Technologies Faces Volatile Trading as Short Interest Declines Amid Mixed Analyst Ratings
Lumen Technologies, (NYSE: LUMN) experienced a significant reduction in short interest during July, marking a pivotal moment for the beleaguered technology company. As of July
Southwest Airlines Prepares for Battle with Elliott Investment Management
A Showdown Looms: Activist Investor Targets Southwest Airlines Southwest Airlines Prepares for Battle with Elliott Investment Management –Â Southwest Airlines (LUV) is bracing for a
FuboTV Stock Surges as Court Blocks Rival Sports Streamer Venu Sports
FuboTV Inc Stock Soars on Legal Win In a significant legal victory, FuboTV Inc (NYSE: FUBO) saw its stock surge in pre-market trading on Monday
AMD Spends $4.9 Billion to Acquire ZT Systems, Bolstering AI Capabilities
A Strategic Move to Enhance AI Portfolio AMD Spends $4.9 Billion in Acquisition – In a landmark deal aimed at expanding its foothold in the
US Stocks Trade Steadily as Focus Shifts to Jackson Hole Symposium
US Stocks Trade Steadily – On Monday, US stock markets showed a steady performance, with major indices hovering near recent highs, following their strongest weekly
Federal Reserve’s Annual Retreat at Jackson Hole: Clues on Upcoming Economic Policy
Federal Reserve’s Annual Retreat: Changing Perspective on Interest Rate Adjustments As the Federal Reserve (Fed) gathers for its annual economic symposium in Jackson Hole, Wyoming,
Five Below Inc. (NASDAQ: FIVE) Highlighted for Surprising Price Action
Five Below, Inc. (NASDAQ: FIVE) has caught the attention of the investment community today with its bullish price action. The company’s shares have moved 8.88% on
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous
